HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Robert Flisiak Selected Research
Robert Flisiak Research Topics
Disease
87
Infections
05/2024 - 12/2003
49
Fibrosis (Cirrhosis)
05/2024 - 09/2002
36
Chronic Hepatitis C
01/2024 - 11/2005
33
COVID-19
05/2024 - 12/2020
33
Chronic Hepatitis B
01/2020 - 12/2003
24
Liver Diseases (Liver Disease)
07/2023 - 11/2005
17
Liver Cirrhosis (Hepatic Cirrhosis)
03/2021 - 09/2002
12
Hepatitis C
01/2022 - 11/2005
10
Coinfection
03/2024 - 01/2012
8
HIV Infections (HIV Infection)
05/2024 - 11/2004
8
Disease Progression
05/2024 - 01/2004
8
Inflammation (Inflammations)
08/2022 - 09/2002
7
Hepatitis
01/2019 - 09/2002
6
Hepatocellular Carcinoma (Hepatoma)
03/2024 - 04/2015
6
Hepatitis B
01/2024 - 09/2002
4
Fever (Fevers)
11/2023 - 07/2021
4
Renal Insufficiency (Renal Failure)
03/2023 - 01/2005
4
Persistent Infection
06/2017 - 01/2015
3
Liver Failure
03/2023 - 06/2005
3
Hemorrhage
11/2021 - 03/2019
3
End Stage Liver Disease
05/2021 - 10/2008
3
Hepatic Insufficiency
03/2021 - 08/2008
3
Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2021 - 09/2012
3
Non-alcoholic Fatty Liver Disease
08/2019 - 09/2017
3
Esophageal and Gastric Varices (Esophageal Varices)
06/2019 - 10/2017
3
Chronic Hepatitis (Chronic Active Hepatitis)
12/2017 - 09/2002
3
Anemia
04/2017 - 06/2011
3
Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
01/2017 - 08/2008
3
Virus Diseases (Viral Diseases)
09/2012 - 09/2007
3
Ulcerative Colitis
01/2005 - 05/2003
2
Croup
05/2024 - 11/2023
2
Genetic Predisposition to Disease (Genetic Predisposition)
01/2023 - 10/2013
2
Communicable Diseases (Infectious Diseases)
01/2023 - 09/2018
2
Neoplasms (Cancer)
09/2022 - 05/2021
2
Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 10/2013
Drug/Important Bio-Agent (IBA)
52
Antiviral Agents (Antivirals)
IBA
05/2024 - 11/2005
29
Interferons
IBA
07/2023 - 12/2003
22
Ribavirin (Virazole)
FDA Link
Generic
07/2021 - 01/2004
14
Hepatitis B e Antigens
IBA
03/2019 - 06/2005
13
Biomarkers (Surrogate Marker)
IBA
06/2023 - 09/2002
11
Hepatitis B Surface Antigens (HBsAg)
FDA Link
01/2024 - 06/2005
11
DNA (Deoxyribonucleic Acid)
IBA
09/2019 - 06/2005
10
Cytokines
IBA
06/2023 - 01/2015
10
Tenofovir (Viread)
FDA Link
10/2019 - 12/2008
10
RNA (Ribonucleic Acid)
IBA
08/2019 - 11/2007
9
ombitasvir
IBA
07/2021 - 06/2016
9
paritaprevir
IBA
07/2021 - 06/2016
9
Lamivudine (Epivir)
FDA Link
01/2011 - 12/2003
8
Vaccines
IBA
09/2023 - 01/2010
8
Interleukin-6 (Interleukin 6)
IBA
01/2023 - 02/2018
8
Ritonavir (Norvir)
FDA Link
07/2021 - 06/2016
8
dasabuvir
IBA
07/2021 - 06/2016
7
Antibodies
IBA
01/2024 - 09/2005
7
glecaprevir and pibrentasvir
IBA
11/2023 - 01/2018
7
Indicators and Reagents (Reagents)
IBA
01/2017 - 08/2002
6
Enzymes
IBA
12/2017 - 08/2002
6
Transforming Growth Factor beta1 (TGF beta 1)
IBA
11/2005 - 09/2002
5
remdesivir
IBA
03/2023 - 12/2020
5
peginterferon alfa-2a (Pegasys)
FDA Link
01/2020 - 06/2005
5
Alanine Transaminase (SGPT)
IBA
11/2018 - 06/2005
5
Sofosbuvir
IBA
01/2018 - 12/2013
5
Interferon-alpha (Interferon Alfa)
IBA
06/2017 - 01/2004
5
telaprevir
IBA
11/2016 - 06/2011
5
Transaminases (Aminotransferases)
IBA
12/2013 - 09/2002
5
Tissue Inhibitor of Metalloproteinase-1
IBA
11/2005 - 09/2002
5
Transforming Growth Factor beta (TGF-beta)
IBA
06/2005 - 08/2002
4
Particulate Matter
IBA
05/2024 - 07/2022
4
Benzo(a)pyrene
IBA
05/2024 - 07/2022
4
tocilizumab (atlizumab)
FDA Link
07/2023 - 01/2021
4
Interleukin-17 (Interleukin 17)
IBA
01/2023 - 06/2015
4
C-Reactive Protein
IBA
01/2023 - 05/2021
4
Autoantibodies
IBA
01/2023 - 09/2012
4
Oxygen (Dioxygen)
IBA
11/2022 - 04/2010
4
Interleukins
IBA
08/2022 - 01/2005
4
COVID-19 Vaccines
IBA
04/2022 - 05/2021
4
Antigens
IBA
03/2019 - 01/2012
4
Metalloproteases (Metalloproteinases)
IBA
11/2005 - 12/2003
3
Interleukin-10 (Interleukin 10)
IBA
01/2023 - 01/2004
3
molnupiravir
IBA
12/2022 - 01/2022
3
Procalcitonin
IBA
08/2022 - 07/2021
3
daclatasvir
IBA
01/2018 - 03/2016
3
Hepcidins
IBA
12/2017 - 08/2008
3
Keratin-18 (Keratin 18)
IBA
01/2017 - 12/2011
3
alisporivir
IBA
10/2015 - 03/2008
3
Simeprevir
IBA
12/2013 - 01/2011
3
adefovir dipivoxil (Hepsera)
FDA Link
01/2011 - 12/2008
3
Interferon alpha-2 (Roferon-A)
FDA Link
10/2010 - 01/2008
3
Cyclophilins (Cyclophilin)
IBA
05/2009 - 09/2007
3
Transforming Growth Factors (Transforming Growth Factor)
IBA
11/2005 - 08/2002
2
Air Pollutants (Pollutants, Air)
IBA
05/2024 - 01/2023
2
fibrin fragment D (D-dimer)
IBA
01/2023 - 09/2022
2
nirmatrelvir and ritonavir drug combination
IBA
12/2022 - 01/2022
2
sofosbuvir drug combination ledipasvir
IBA
01/2022 - 01/2018
Therapy/Procedure
72
Therapeutics
05/2024 - 12/2003
6
Liver Transplantation
03/2024 - 06/2005
4
Retreatment
01/2023 - 12/2013
4
Aftercare (After-Treatment)
07/2021 - 09/2003
4
Duration of Therapy
03/2020 - 09/2012
3
Blood Transfusion (Blood Transfusions)
08/2023 - 06/2008
3
Kidney Transplantation
01/2021 - 01/2005